no statement of use filed
on 04 Sep 2023
Last Applicant/ Owned by
Route 206 & Province Line Road
Princeton
NJ
08543
Serial Number
90605994 filed on 26th Mar 2021
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies
No 90605994
No Service/Collective Mark
No 00159597-US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
05th Sep 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
04th Sep 2023 | ABANDONMENT - NO USE STATEMENT FILED |
02th Aug 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
02th Aug 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
02th Aug 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
31st Jan 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
06th Dec 2022 | PUBLISHED FOR OPPOSITION |
06th Dec 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
16th Nov 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
31st Oct 2022 | EXAMINERS AMENDMENT -WRITTEN |